The NH 2 -terminal somatomedin B domain (SMB; residues 1 -44) of human vitronectin (VN) contains eight Cys residues organized into four disulfide bonds, and is required for the binding of type 1 plasminogen activator inhibitor (PAI-1). In the present study, we map the four disulfide bonds in recombinant SMB (rSMB) and evaluate their functional importance. Active rSMB was purified from transformed Escherichia coli by immunoaffinity chromatography using a monoclonal antibody that recognizes a conformational epitope in SMB (mAb #153). Plasmon surface resonance (BIAcore) and competitive ELISA analyses demonstrate that the purified rSMB domain and intact urea- Selective reduction/ S-alkylation of these two disulfide linkages caused the complete loss of PAI-1 binding activity. The other two pairs of disulfide bonds in the COOH-terminal portion of rSMB were identified as Cys 25 -Cys 31 and Cys 32 -Cys 39 by protease-generated peptide mapping of partially reduced and S-alkylated rSMB. These results suggest a linear uncrossed pattern for the disulfide bond topology of rSMB which is distinct from the crossed pattern present in most small disulfide bond-rich proteins.
INTRODUCTION
Vitronectin (VN) is a 75kDa adhesive glycoprotein that is present in plasma and the extracellular matrix, and it plays a significant role in a number of biological processes (1) .
For example, VN is anchored to the extracellular matrix via collagen or proteoglycanbinding, and it promotes cell attachment, spreading and migration through specific interactions of its single Arg-Gly-Asp (RGD) sequence with cellular integrins, such as alpha V ß3 (2, 3) , alpha V ß 5 (4) , and alphaIIbß 3 (3, 5) . Upon binding to VN, these integrins activate signaling pathways and regulate cytoskeletal reorganization and kinase activation (6) . VN also binds to urinary type plasminogen activator receptor (uPAR) on the cell surface, an interaction that also promotes cell adhesion (7) (8) (9) (10) . In addition to its functions in cell adhesion and migration, VN was shown to act as an inhibitor of the cytolytic reactions of complement by binding to complement factor C5b-7 (1) . In this regard, it is now clear that VN is identical to the S-protein of complement (11, 12) . Finally, VN interacts with several critical proteins that regulate thrombosis and fibrinolysis. For example, it protects thrombin from rapid, heparin-dependent inactivation by antithrombin III, possibly because it acts as a heparin scavenger (13) . It also binds to type 1 plasminogen activator inhibitor Instruments, Rochester, NY) and the supernatant obtained after centrifugation at 31,000 X g for 30 min. was applied to and eluted from an affinity column containing His-bind resin according to the manufacturer's instructions (Clontech, Palo Alto, CA). For further purification, the eluted rVN1-97 was subjected to immunoaffinity chromatography using the conformation specific mAb #153 conjugated to a Cellufine column (1.0 X 6 cm). The column was prepared according to the instructions provided by the manufacturer, with 5 mg of mAb #153 immobilized onto 1 ml of Cellufine (Millipore, Danvers, MA). The column was equilibrated with 50 mM Tris-HCl (pH 7.4) containing 0.1M NaCl. After loading the sample (i.e., rVN1-97), the column was washed with 1M NaCl. Bound rVN1-97 (b-rVN1-97) was then eluted with 0.1M Gly-HCl (pH 2.5) and the column and eluant were immediately neutralized with 1M Tris. The unbound rVN1-97 in the flow through fraction (ub-rVN1-97) contained small amounts of dimeric rVN1-97. The dimers were removed by gel filtration on a HiLoad Superdex 75 column (1.6 X 60 cm) (Amersham Pharmacia Biotech, Uppsala, Sweden) equilibrated with 50 mM Tris-HCl (pH 7.4).
Preparation of VN1-51-To prepare a smaller peptide containing the SMB region (i.e., VN1-51), we treated r VN1-97 with CNBr (see Fig. 1 ), and then performed immunoaffinity chromatography using the conformation-specific mAb #153-conjugated gel followed by gel filtration chromatography. Briefly, rVN1-97 (60 mg), which had been purified by using the His-bind resin, was reacted with 80 mg of CNBr in 70% formic acid for 24 h at room temperature. The reaction product was dried, dissolved in water, and dialyzed for 24 h at 4°C against 50 mM Tris-HCl (pH 7.4) containing 0.1M NaCl. After dialysis, the cleaved rVN1-97 was applied to the mAb #153-conjugated Cellufine column as described above, the column was washed and bound recombinant VN1-51 (b-rVN1-51) Determination of PAI-1 Binding Activity-The PAI-1 binding activity of VN and recombinant VN fragments was determined using a competitive binding assay as previously described (30, 31) . In brief, 100 µl of urea-activated VN (0.1 µg/ml in PBS) was adsorbed to microtiter wells by incubation overnight at 4°C. The wells were blocked by incubation with 5% BSA for 2 h at 37°C. In separate tubes increasing amounts of VN or VN fragments were pre-incubated with PAI-1 (0.1 nM) at room temperature for 10 min, and then the mixture was added to the VN-coated wells. The samples were diluted with 20 mM Tris-HCl, pH 7.4, containing 0.1 M NaCl, 0.1% Tween 20 (TBS/T) and 0.1% BSA.
After incubation for 1 h at 37°C, the wells were washed four times with TBS/T, and bound PAI-1 was detected using rabbit anti-PAI-1 antibody followed by biotin-conjugated goat anti-rabbit antibody and streptavidin-alkaline phosphatase. The reaction was developed using PNPP substrate, and absorbance was measured at 405 nm after development was stopped by addition of 0.75 M NaOH.
We recently employed surface plasmon resonance to perform in a detailed kinetic analysis of the interaction of PAI-1 with both recombinant VN1-97 and with urea-activated VN (34) . These studies indicated that the association and dissociation curves were similar for urea-activated VN and VN1-97, and that these molecules bound PAI-1 with by guest on http://www.jbc.org/ Downloaded from approximately equal efficiencies (34) . Thus, the PAI-1 binding activity of VN and VN fragments also was determined by surface plasmon resonance analysis using the BIAcore system. All materials were purchased from BIACORE (Uppsala, Sweden). To prepare rVN1-97-immobilized sensor chips, 20 µg/ml rVN1-97 in 10 mM phosphate buffer (pH 4.0) was injected onto the sensor chips (CM5) and immobilized by using the amine coupling kit. The chip was washed with BIAcore running buffer (HBS-EP: 10 mM HEPES, pH 7.4, 0.15 M NaCl, 3 mM EDTA, and 0.005% surfactant P20), and the PAI-1 sample (diluted with HBS-EP) was then injected onto the chip. The amount of bound PAI-1 was determined by measuring the resulting signal expressed as resonance units (RU). All experiments were carried out at 25°C, and the sensor chip was regenerated by washing with 0.1 M HCl.
Quantitation of the Binding of rVN1-97 to Anti-VN mAbs-
The binding affinity of rVN1-97 for various anti-VN mAbs was determined in BIAcore experiments using a rVN1-97-immobilized sensor chip and increasing concentrations of anti-VN mAbs #1244 and #153 as described (34) . In preliminary studies, we demonstrated that mAbs #153 and #1244 bind to urea-activated VN on the sensor chip with Kds of 5.9 nM and 14 nM, respectively.
These mAbs bind to VN 1-97 with similar affinities (data not shown).
Partial Reduction and S-Alkylation of rVN1-51-To prepare partially reduced and S-alkylated rSMB, the purified rVN1-51 was partially reduced with TCEP under acidic conditions, and then S-alkylated with NEM. In brief, the lyophilized rVN1-51 (100 µg) was dissolved in 90 µl of 6 M guanidine HCl containing 0.75 M sodium acetate, pH 4.6, and then 10 µl of 0.1M TCEP was added. The peptide solution was incubated at 45°C for 20 min under N 2 , and then 8 µl of 1 M NEM was added, and the mixture was incubated at by guest on http://www.jbc.org/ Downloaded from 37°C for 1 h. The mixture was subjected to reversed phase chromatography using a BetaBasic CN column (4.6 X 250 mm, 5 µm, Western Analytical Products, Murrieta, CA) in 0.1% (v/v) aqueous trifluoroacetic acid. The partially reduced rVN1-51 isomers were separated with a linear gradient (from 0 to 55%) of buffer B (80% acetonitrile in 0.1% (v/v) aqueous trifluoroacetic acid) at a flow rate of 0.5 ml per min.
Proteolytic Digestion of Partially Reduced and S-Alkylated rVN1-51-For pepsin digestion, the partially reduced and S -alkylated r VN1-51 (100 µg) was lyophilized, dissolved in 0.1% (v/v) aqueous trifluoroacetic acid, and then digested with pepsin (2 µg) at 37°C for 20 h. The sample was subjected to reversed phase chromatography using a Vydac C18 column (4.6 X 250 mm, 5 µm, Western Analytical Products) and separated using a linear gradient of buffer B from 0 to 50% at a flow rate of 0.5 ml per min. For endoproteinase Glu-C digestion, the partially reduced, S-alkylated and lyophilized rVN1-51 was dissolved in 0.1M ammonium bicarbonate buffer, pH 7.8, containing 2 M urea, and then digested with Glu-C protease (4% w/w) by incubation at 37°C for 24 h. The digest was directly subjected to reversed phase chromatography using a Vydac C18 column.
Complete Reduction with DTT and S -Alkylation with 4VP-The remaining disulfide bonds in partially reduced and S-alkylated rVN1-51 were completely reduced by incubation at 45°C for 1 h with 50 mM DTT in 0.2M Tris-HCl, pH 8.5, containing 6 M guanidine HCl. The reduced Cys residues were then S-alkylated by incubation for 30 min.
with excess 4VP at room temperature. The modified products were further purified by reversed phase chromatography using a C18 column. Miscellaneous-SDS-PAGE was performed in slab gels according to Laemmli (43) .
Reduction of samples was carried out by the addition of 5% 2-mercaptoethanol to the sample buffer followed by boiling for 5 min. The protein concentration was determined by BCA protein assay (Pierce, Rockford, IL) using BSA as a standard. The concentration of rVN1-97 and rVN1-51 was also determined by amino acid composition analysis (Protein and Nucleic Acids Core Facility at The Scripps Research Institute).
RESULTS

Molecular
Characteristics of the two rVN1-97 forms-Recombinant VN1-97 was expressed in Escherichia coli and purified by immunoaffinity chromatography using the conformation-specific mAb #153 conjugated to a Cellufine column. The recovery of brVN1-97 from the mixture of b-rVN1-97 and ub-rVN1-97 was approximately 10% (data not shown). Thus, most of the rSMB expressed in the cytoplasm of Escherichia coli was misfolded and inactive, even though it was expressed as a fusion protein linked to the COOH-terminus of thioredoxin. The rVN1-97 form which specifically bound to the gel (brVN1-97) migrated as a single band with a molecular weight of approximately 42kDa on SDS-PAGE under reducing conditions (Fig. 2, lane 4) ; its mobility was slightly faster when SDS-PAGE was performed under non-reducing conditions (Fig. 2, lane 2) . Results from mass spectrometry showed that the molecular mass of b-rVN1-97 was 27,908 Da, and protein sequencing revealed that its NH 2 -terminal amino acid sequence was SDKIIH (Table   I ). Thus, the Met-Ser peptide bond at the NH 2 -terminus of b-rVN1-97 appears to have been cleaved, perhaps by an aminopeptidase such as methionine aminopeptidase (44) . The rVN1-97 form which did not bind to the mAb #153-conjugated gel (ub-rVN1-97) contained a trace amount of the dimeric form, and these dimers were removed by gel filtration (data not shown). The purified monomeric ub-rVN1-97 resembled b-rVN1-97 in that it showed a single band upon analysis by SDS-PAGE, and this band migrated at the same positions as b-rVN1-97 under both non-reducing and reducing conditions (Fig. 2, lanes 3 and 5) . The observed mass of ub-rVN1-97 (27,913 Da) was also similar to that of b-rVN1-97 (Table I) , and both molecules contained the same NH 2 -terminal amino acid sequence (Table I) . Thus, ub-rVN1-97 also lacked a Met residue at the NH 2 -terminus.
The ability of two different anti-VN mAbs to recognize the bound and unbound forms of rVN1-97 was measured by BIAcore analysis. As shown in Fig. 3A , the b-rVN1-97 form was recognized by both mAbs #153 and #1244, while the ub-rVN1-97 form was recognized by mAb #1244 but not by #153. The conformation specific epitope detected by mAb #153 is located in the SMB domain (i.e., residues 1-44; see Table   I ), the structural changes in it that eliminate its interaction with mAb #153 also result in the loss of PAI-1 binding activity. (Table I) . It is likely that other amino acid residues in these rVN1-51s may be chemically modified during CNBr treatment and/or the purification procedure, and that these modifications account for the increase in molecular mass by 28 for both the homoserine lactone containing form (5,764
Characterization of the Active Form of rVN1-51-
Da becomes 5,792 Da) and the homoserine containing form (5,782 Da becomes 5,810 Da) of rVN1-51. These conclusions are supported by the observation that only a single NH 2 -terminal amino acid sequence was detected in the preparation (i.e., DQESCK), and that this sequence was identical to the amino acid sequence predicted from VN cDNA (Table I) .
Moreover, each of these forms of rVN1-51 had the same PAI-1 binding activity (data not shown). TCEP at pH 4.6, followed by S-alkylation with NEM to mark the position of the reduced Cys residues (45-48). The combination of TCEP with NEM at low pH is particularly useful for the identification of disulfide bond pairs since it minimizes exposure of the protein to alkaline conditions that may allow the exchange of disulfide-linkages (48, 49). In preliminary experiments, we subjected rVN1-51 to reduction with TCEP for increasing lengths of time, and observed that all four disulfide bonds were already completely reduced after only 20 min (data not shown). Therefore, to prepare partially reduced rVN1-51
Identification of the Disulfide Bond Pairs Located in the NH
isomers, rVN1-51 was reacted with TCEP for only 2 min and then the resulting isomers were separated by reversed phase chromatography. Because of the short treatment times, only a small fraction of the sample was reduced (Fig. 6) . However, the partially reduced products obtained from active rVN1-51 still separated into several peaks upon analysis by reversed phase chromatography.
The number of disulfide bonds that were reduced and S-alkylated in some randomly selected major peaks (i.e., N1-N7, Fig. 6 ) was determined by subjecting the individual peaks to analysis by mass spectrometry. The calculated increase in mass due to S-alkylation is 126.1 (i.e., 1 Da for reduction, 125.1 Da for alkyation of MEM). Thus, the number of alkylated cysteines can be determined by using the equation:
(observed mass) -(calculated mass) 126.1
As shown in Table II , the observed masses of the rVN1-51 forms in peaks N1 and N2 were similar to those calculated for intact rVN1-51, except that the molecules contained a COOH-terminal homoserine (5,784 Da) or homoserine lactone (5,766 Da), respectively. In contrast, the masses of the rVN1-51 forms in peak N7 were consistent with complete reduction and S-alkylation of all eight Cys residues. The masses of the partially reduced respectively. Thus, the rVN1-51 forms in peak N3 contain two NEM-alkylated Cys residues with either homoserine lactone or homoserine at the COOH-terminus. Finally, these considerations indicate that peaks N4 and N5 contain 4 and 6 alkylated Cys residues, respectively.
In order to identify the pair of NEM-alkylated Cys residues in peak N3, the partially reduced sample was directly subjected to protein sequencing. As shown in Table III Table III ). The rVN1-51 form from peak N2 had the same PAI-1 binding activity as the rVN1-51 form from peak N1 (data not shown). The PAI-1 binding activity of the rVN1-51 form containing reduced Cys 5 -Cys 9 (peak N3, Fig. 6 ) was significantly, but not completely, decreased (Fig. 7) . However, the rVN1-51 form in which both Cys 5 -Cys 9 and Cys 19 -Cys 21 were reduced and S-alkylated (peak N4, fig. 6 ), lacked detectable PAI-1 binding activity (Fig. 7) . Thus, the protein structure created by the disulfide-linkages between Cys 5 -Cys 9 and Cys 19 -Cys 21 at the NH 2 -terminal portion of the rVN1-51 is essential for PAI-1 binding.
Identification of the Two Disulfide Bond Pairs Located in the COOH-terminal
Portion of Active rVN1-51-In order to identify the other two pairs of disulfide bonds in the COOH-terminal portion of rVN1-51, we isolated the partially reduced forms of rVN1-51 in which three disulfide bonds, and therefore six Cys residues, were reduced and Salkylated with NEM. As shown in Table II , the rVN1-51 forms in peaks N5 and N6 (see Fig. 6 ) consist primarily of rVN1-51 containing six NEM-alkylated Cys residues. We initially attempted to identify the one intact disulfide bond pair in peak N6 by direct protein sequencing. This analysis showed that this rVN1-51 form had the NH 2 -terminal amino acid sequence, DQESCesKGRCesTEGFNVDKKCesQCesDELCSYYQSCCesT (residues 1-33). to confirm these disulfide bond pair assignments, we digested the rVN1-51 in peak N5 (see Fig. 6 and Table II ) with endoproteinase Glu-C, and separated the resulting peptides by reversed phase chromatography. The peptides were then identified by mass spectrometry followed by protein sequencing. As shown in panel A of Fig. 8 and in Table IV were unable t o determine which of these Cys residues was connected to Cys 25 . To overcome this problem, we combined peaks N5 and N6 (see Fig. 6 and Table II) , digested the mixture with pepsin, and then analyzed the peptides for the presence of an intact disulfide bond b y reversed phase chromatography, mass spectrometry, and protein sequencing. As shown in panel B of Fig. 8 and in Table IV , the peptide derived from the very COOH-terminal portion of the SMB domain was clearly identified in peak 4 since it contained the sequence TAECesKPQVTR GDVF (residues 36-49). Thus, the Cys 39 residue was S-alkylated with NEM. The protein sequencing data suggested that peak 3 ( Fig. 8 ) may also contain a peptide with one intact disulfide bond pair. In this case, the peptide with the sequence CS (residues 25-26) appears to be directly linked to the YYQSC peptide (residues 27-31) via a disulfide bond. To prove this intact disulfide bond pair, the reduced and alkylated peptides in peak 3 were completely reduced and further S-alkylated with 4VP.
The peptides containing the 4VP-alkylated Cys (Cpe) residues were then isolated by reversed phase chromatography. As shown in panel C of Fig. 8 , and in Table IV, peaks 5 and 6 contained CpeS and YYQSCpe peptides, respectively, in which the Cys 25 and Cys 31 residues were both S-alkylated with 4VP. This observation indicates that the rVN1-51 in peak N5 and N6 (Fig. 6) 
DISCUSSION
The active form of PAI-1 in solution is relatively unstable and rapidly changes into the inactive or latent conformation (50) . This conformational change is characterized by a dramatic structural rearrangement, with the reactive center loop of the inhibitor being inserted into ß-sheet A as the central ß-strand s4A (51) . This alteration in the structure of active PAI-1 is accompanied by a decrease in the availability of its reactive site for tissuetype and urinary-type plasminogen activators, resulting in the loss of inhibitory activity.
Interestingly, the active conformation of PAI-1 can be stabilized by binding to VN, an interaction that results in a two-to three-fold increase in the half-life of the inhibitor (19). These considerations emphasize the importance of identifying the disulfide-linkages in the SMB domain in order to begin to understand its tertiary structure.
In order to determine the disulfide bonds present in the SMB domain of human VN, the correctly folded and biologically active form of rSMB was purified to homogeneity and characterized biochemically. For this purpose, rSMB was expressed in transformed
Escherichia coli as a fusion protein with thioredoxin, and the active form was purified from the mixture of active and inactive forms by immunoaffinity chromatography using a column of mAb #153-conjugated gel. This mAb recognizes an immunoepitope within the SMB domain, and inhibits the binding of PAI-1 to VN (31) . Moreover, this mAb only weakly recognizes VN in Western blots, and treatment of VN with reducing agents destroys the ability of both PAI-1 and mAb #153 to bind to the SMB domain (36). These results indicate that mAb #153 recognizes a conformational epitope which is in close proximity to the PAI-1 binding site and is created by correctly formed disulfide-linkages. This epitope is presumably masked or altered in the inactive form of SMB. Taken together, these observations indicate that mAb #153 is a useful tool for distinguishing between the active and inactive forms of SMB. This conclusion is supported by the observation that the PAI-1 binding activity of the purified rSMB was similar to that of urea-activated VN itself (Fig. 4) .
However, the form of rSMB that did not bind to the mAb #153-conjugated gel, lacked PAI-1 binding activity (Fig. 4) , even though it had the same molecular mass and NH 2 -terminal amino acid sequence as the active form (Table I) .
A variety of approaches were taken to identify the four pairs of disulfide bonds present in the active human SMB domain. We initially attempted to cleave the intact and unreduced SMB domain using trypsin, endoproteinase Glu-C, pepsin, and thermolysin, but by guest on July 15, 2017
http://www.jbc.org/ Downloaded from the recombinant peptide was relatively resistant to these proteinases (data not shown). We next employed the partial reduction and S-alkylation method, an approach that has been widely used for determining the disulfide-linkages present in small disulfide bond-rich proteins (45) (46) (47) (48) (49) . This method relies on partial reduction by TCEP at low pH, followed by reversed phase chromatography to separate the partially reduced and S-alkylated products.
The purified peptides are then analyzed by protein sequencing to determine the location of the S-alkylated Cys residues. By using this approach, two pairs of disulfide bonds, Cys 5 - Fig. 9 ).
Harrison and Sternberg (53) previously reported that small disulfide bond-rich proteins or functional domains (which are defined as having less than 100 amino acid residues and two or more disulfide bonds) have a structural motif termed the disulfide ß-cross, a structural feature imposed by four closely clustered Cys residues. This structural motif consists of a ß-hairpin loop with two disulfide bonds connecting each strand of the hairpin to two adjacent Cys residues. Importantly, the disulfide-linkages are generally overlapping and crossed (53) . This structural motif may provide a folding nucleus in small disulfide bond-rich proteins and thus may play a crucial part in determining both the structure and stability of these proteins. The four disulfide-linkages of several toxin-agglutinins such as snake toxin (54), spider toxin (55), scorpion neurotoxin (56) and hevein (57) , as well as the disintegrin echistatin (45) are shown in panel B of Fig. 9 . This complex crossed pattern of disulfide bonds is strikingly different from the linear uncrossed pattern proposed for the rSMB domain (Fig. 9A) . However, a similar linear and uncrossed pattern was recently described for the disulfide bond topology of the fifth epidermal growth factor (EGF)-like domain of thrombomodulin (46, 58, 59) . This domain, which is essential for thrombin binding, has three simple disulfide-linkages in an uncrossed pattern (Fig. 9 , panel C), and thus differs from the crossed pattern of the other EGF-like domains (47) . It is interesting to note that the thrombin binding affinity of synthetic peptides containing the "uncrossed" fifth EGF-like domain was nearly an order of magnitude higher than that of synthetic peptides containing the "crossed" fifth EGF-like domains (58) . NMR analysis also demonstrated that the fifth "uncrossed" EGF-like domain was much more mobile than the fourth EGF-like domain and that the residues in the fifth EGF-like domain, including the Cys residues, showed shifts upon thrombin binding (59) . These results suggest that the uncrossed disulfide bonds may contribute to the conformational flexibility of the fifth EGFlike domain, and that this may be important for interactions with thrombin.
During the course of these studies, we also investigated the relationship between the disulfide-linkages of the SMB domain and its PAI-1 binding activity. As previously mentioned, Deng et al. (33) reported that replacing any single Cys residue with alanine severely decreased the PAI-1 binding activity of the SMB domain. However, these investigators could not identify the critical disulfide bond pairs for PAI-1 binding since each of these replacements created a free reactive Cys residue that in turn would be expected to disrupt the overall structure of the molecule. Therefore, in the current study, we compared the PAI-1 binding activity of partially reduced and S-alkylated-rVN1-51 with that of intact and unreduced rVN1-51. As shown in Fig. 7 binding. Because the disulfide-linkages in the COOH-terminal portion of SMB were more resistant to reduction, we could not prepare rVN1-51 in which these two disulfide-linkages were selectively reduced. Thus, their role in PAI-1 binding remains to be determined.
Finally, it is important to note that the unusual linear uncrossed pattern of disulfide bonds present in active recombinant SMB may not be present in the SMB domain of ureaactivated vitronectin itself. Although this issue cannot be resolved until the structure of native SMB is determined, a number of considerations argue against this possibility. These considerations suggest instead that rSMB and native SMB are substantially similar. For example, both molecules are recognized by mAb 153, a conformationally dependent mAb.
The fact that both forms of SMB compete with each other for binding to this mAb (34) , and that this mAb does not recognize denatured or misfolded SMB (36), suggests that the SMB domain is correctly and similarly folded in both SMB forms. This conclusion is supported by the observation that both forms of SMB bind active PAI-1 with similar high affinities pairing, and therefore, substantially correct folding. Finally, we have identified five additional mAbs that not only bind to recombinant and native SMB, but also compete with PAI-1 for binding to these molecules (41) . These mAbs recognize three separate, partially overlapping epitopes within SMB. Thus, recombinant SMB and native SMB are recognized by six conformation-dependent mAbs and by PAI-1 itself, and these molecules bind to different regions of SMB (41). These observations make it very unlikely that the disulfidebonds in rSMB differ from those present in native SMB, and suggest that the disulfide bonds in native SMB also are organized into a linear non-crossed pattern. As mentioned, definitive proof for this conclusion will only come when the structure of native SMB is determined. Whatever the case, the linear uncrossed disulfide bond pattern in recombinant SMB does, in fact, define a high affinity binding site for PAI-1. Thus, the structure of rSMB itself will be of considerable interest to investigators in the field, especially those interested in PAI-1 inhibitors (60), even if it differs from the structure of native SMB.
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We acknowledge the technical assistance of Nancy V. Wagner. We would like to thank Scott A. Curriden, Drs. Sadaaki Iwanaga (Kyushu University, Japan), Akira Katsumi were incubated with 0.1 nM PAI-1 for 10 min at room temperature. The mixtures were then added to denatured VN-coated wells, and the amount of bound PAI-1 was determined as described in the legend to Fig. 4 . partially reduced and S-alkylated rVN1-51 in peak N5 (Fig. 6) , in which three disulfide bonds were reduced (see Table II ), was digested with endoproteinase Glu-C, and the intact disulfide bond pair-containing peptides were isolated by reversed phase chromatography using a C18 column. Panel B, pepsin-generated peptide map. The mixture of the rVN1-51 forms in peaks N5 and N6 ( Fig. 6 and Table II) Table II Analysis of partially reduced and S-alkylated rVN1-51 by mass spectrometry
The partially reduced and S-alkylated rVN1-51 isomers were separated by reversed phase chromatography (see Fig. 6 ), and peak fractions were analyzed by mass spectrometry. The calculated increase in mass due to alkylation is 126.1. The number of S-alkylated Cys residues in each peak was estimated from the following equation: (observed mass-calculated mass)/126. The partially reduced and S-alkylated rVN1-51 isomers were separated by reversed phase chromatography (see Fig. 6 and Table II) Cys5-Cys9, Cys19-Cys21
Ces; NEM-alkylated Cys residue was detected as S-ethylsuccimidecysteine (Ces). C; Cys residue that remained in a disulfide bond and was registered as a blank in protein sequencing.
Table IV
Identification of the disulfide bond pairs located in the COOH-terminal portion of active rVN1-51
The partially reduced and S-alkylated rVN1-51 in peak N5 (Fig. 6 ) and the mixture of peaks N5 and N6 (Fig. 6 ) was digested with endoproteinase Glu-C and pepsin, respectively, and the peptides containing an intact disulfide bond pair were isolated by reversed phase chromatography followed by mass spectrometry and protein sequencing. 
